Involvement of HMGB1-mediated ferroptosis in systemic diseases
Frontiers in Cell and Developmental Biology · 03.10.2025 · 13
DOI: 10.3389/fcell.2025.1676941 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 03.10.2025. Verfasst von Lijie Lv und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Lequn Branch, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ferroptosis is a distinct, iron-dependent form of regulated cell death characterized by lipid peroxidation and redox imbalance. High-mobility group box 1 (HMGB1), a nuclear protein with strong immunomodulatory capacity, has emerged as a key regulator in ferroptosis-related pathologies. Acting both as a downstream effector released during ferroptotic cell death and as an upstream amplifier of inflammation, immune activation, and metabolic dysfunction, HMGB1 plays a context-dependent dual role in disease progression. In tumor settings, HMGB1-mediated ferroptosis enhances antitumor immunity and suppresses tumor growth. Conversely, in non-neoplastic diseases, such as ischemia-reperfusion injury and inflammatory disorders, HMGB1 release exacerbates tissue damage and immune dysregulation. This review comprehensively summarizes the molecular mechanisms of HMGB1-induced ferroptosis, including its regulation via autophagy–ferritinophagy and redox signaling pathways. We further examine how the HMGB1–ferroptosis axis contributes to systemic diseases affecting the respiratory, digestive, nervous, circulatory, urinary, locomotor, endocrine, reproductive, and immune systems. Finally, we discuss emerging therapeutic strategies that target this axis with an emphasis on disease-specific interventions modulating ferroptosis, inflammation, and immune responses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Lequn Branch, The First Hospital of Jilin University, Changchun, China.
- Department of Nursing, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
- Department of Anorectal Diseases, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
- Department of Pharmacy, Lequn Branch, The First Hospital of Jilin University, Changchun, China.
Zitieren
APA
Lv, L., Wang, Y., Lv, X., & Miao, Q. (2025). Involvement of HMGB1-mediated ferroptosis in systemic diseases. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1676941
Vancouver
Lv L, Wang Y, Lv X, Miao Q. Involvement of HMGB1-mediated ferroptosis in systemic diseases. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1676941
BibTeX
@article{Lv2025,
author = {Lv, Lijie and Wang, Yue and Lv, Xuan and Miao, Qiuli},
title = {Involvement of HMGB1-mediated ferroptosis in systemic diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1676941}
}
EUVIMED